Protara sees 66% 6-month bladder cancer response rate, but drops to 33% at 12 months
Protara sees 66% 6-month bladder cancer response rate, but drops to 33% at 12 months
Protara sees 66% 6-month bladder cancer response rate, but drops to 33% at 12 months
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.